Overview
- Scott Adams posted that Kaiser Permanente–Northern California approved him for the FDA‑cleared radioligand therapy Pluvicto but had not scheduled the IV, saying he was declining fast.
- President Trump replied “On it!” while HHS Secretary Robert F. Kennedy Jr. asked how to reach Adams, and White House aide Dan Scavino said senior officials were already tracking the case with CMS Administrator Mehmet Oz.
- STAT reported, citing a single anonymous source, that Trump contacted Oz, who then spoke with Adams and Kaiser representatives, with Kaiser planning to quickly resolve scheduling.
- Kaiser stated Adams’ oncology team is working closely with him on next steps already underway and noted it has treated more than 150 Northern California patients with Lu‑177 PSMA (Pluvicto).
- By Monday, Adams wrote that he was grateful and “getting what I need now,” as reporters continued seeking clarity on how any White House outreach would translate into concrete scheduling.